Target intelligence / Profile preview

Cytochrome P450 2F1 (CYP2F1)

Target
CYP2F1
Molecular classification
Enzyme, Oxidoreductase, Cytochrome P450 monooxygenase
01

Overview

Cytochrome P450 2F1 (CYP2F1) is a member of the cytochrome P450 superfamily of heme-containing monooxygenase enzymes, predominantly expressed in human lung tissue. CYP2F1 is involved in the oxidative metabolism of xenobiotics and endogenous toxins, catalyzing reactions such as monooxygenation and dehydrogenation of substrates like naphthalene, ethoxycoumarin, and 3-methylindole. These reactions contribute to drug metabolism, detoxification, and the biosynthesis of cholesterol and steroids. The enzyme is membrane-bound in the endoplasmic reticulum. Genetic variations in CYP2F1 may result in substantial interindividual differences in enzyme activity and susceptibility to chemically induced lung toxicity or carcinogenesis, although current evidence does not support a major direct role in lung cancer pathogenesis.

Other names
Cytochrome P450 family 2 subfamily F member 1CYPIIF1C2F1CYP2Fcytochrome P450, family 2, subfamily F, polypeptide 1cytochrome P450, subfamily IIF, polypeptide 1flavoprotein-linked monooxygenasemicrosomal monooxygenasexenobiotic monooxygenase
02

Mechanism of action

Oxidative metabolism (monooxygenation and dehydrogenation) of substrates including endogenous and xenobiotic compounds

03

Biological functions

Drug metabolismXenobiotic metabolismLipid metabolismSteroid and cholesterol biosynthesis
04

Disease associations

CancerPulmonary toxicityOther chemically induced diseases
05

Safety considerations

Interindividual variability in metabolism leading to differences in toxic response to environmental pneumotoxicants (e.g., naphthalene, 3-methylindole)Genetic polymorphisms resulting in non-functional or truncated enzyme variants
06

Interacting drugs

Naphthalene

2 more in the full profile.

07

Biomarkers

CYP2F1 allelic variants (for metabolic activity/interindividual variation)

Beyond the preview

Go deeper on Cytochrome P450 2F1 (CYP2F1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 2F1 (CYP2F1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call